Table 3.
One‐Way Deterministic Sensitivity Analyses and Probabilistic Sensitivity Analysis
| Parameters | Base case | Min value | Max value | Distribution |
|---|---|---|---|---|
| Percent of patients at nutrition risk 51 | 37.25% | 26.25% | 48.24% | β |
| Reduction in the number of hospital days 51 | −0.35 | −1.04 | 0.34 | Normal |
| Percent of days with nutrition therapya | 80.00% | 70.00% | 90.00% | β |
| Percent of days without nutrition therapya | 20.00% | 10.00% | 30.00% | β |
| Percent enteral usea | 69.10% | 57.00% | 80.00% | β |
| Percent parenteral usea | 10.63% | 10.00% | 10.00% | β |
| Percent enteral + parenteral usea | 20.27% | 10.00% | 33.00% | β |
| Percent of enteral use among those who used enteral + parenterala | 80% | 70.00% | 90.00% | β |
| Percent parenteral use among those who used enteral + parenterala | 20% | 10.00% | 30.00% | β |
| Enteral nutrition costb | R$30 | R$30.00 | R$45.00 | Log‐normal |
| Oral supplement costb | R$30 | R$30.00 | R$45.00 | Log‐normal |
| Parenteral nutrition costb | R$60 | R$60.00 | R$90.00 | Log‐normal |
| Risk of readmission in patients with nutrition risk or malnourishedc | 31.28% | 23.16% | 39.41% | β |
| Risk of readmission in patients without nutrition riskc | 19.73% | 14.76% | 24.71% | β |
| Readmission risk reduction in patients receiving nutrition therapy 51 | 0.94 | 0.79 | 1.12 | Log‐normal |
| Reduction of the risk of mortality in patients that were at nutrition risk or malnourished and received nutrition therapyc | 0.88 | 0.64 | 1.21 | Log‐normal |
max, maximum; min, minimum.
a Clinical expertise.
bReimbursement and market value (in real, Brazilian money).
cLiterature meta‐analysis (submitted).